Fasting Mimicking Diet and Beige/Brown Adipose Tissue in Humans
Effect of Fasting Mimicking Diet on the Activation of Beige/Brown Adipose Tissue in Humans
1 other identifier
interventional
26
1 country
1
Brief Summary
Obesity today has become one of the main public health concerns. As a consequence, different strategies have arisen to fight weight gain. One of the alternative strategies to increase the success of therapeutic approaches to weight loss is the increase in energy expenditure, through thermogenesis, regulated by the beige/brown adipose tissue (BAT). Studies have shown that beige/BAT has a strong correlation with body weight regulation. It has also been demonstrated that cold exposure activates beige/BAT. Recent studies, mainly in animal models, suggest that beige/BAT can also be activated by specific food and nutrients. Concomitantly, new dietary interventions, to treat obesity, have also been studied. One of these dietary interventions is the Fasting Mimicking Diet (FMD). Since FMD is high in unsaturated fat, and clinical trials have shown that FMD interventions reduced body weight and improved metabolic health, there is a possible association between this diet and the activation of beige/BAT. The aim of this is study is to investigate the effect of Fasting Mimicking Diet on the activation of beige/brown adipose tissue, in humans with overweight. This will be an open clinical trial with the duration of three consecutive months (three cycles of the FMD diet). There will be an FMD and a control group. The following data will be collected before and after the intervention, for each group: dietary intake and physical activity data, evaluation of beige/brown adipose tissue activation (Positron Emission Tomography - PET with fluoride-18-labeled fluorodeoxyglucose (18F-FDG) in combination with computed tomography - PET/CT scan, Thermal Imaging, BAT adipokines and genes related to BAT activity), basal metabolic rates and caloric needs (Indirect Calorimetry), anthropometric measures and body composition (DEXA scan), lipid profile and inflammatory markers. Data will be expressed as mean and standard deviation and the variables will be compared by Student's t-test or ANOVA, for repeated measures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started May 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2020
CompletedFirst Submitted
Initial submission to the registry
May 4, 2020
CompletedFirst Posted
Study publicly available on registry
May 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedMay 13, 2020
May 1, 2020
1.2 years
May 4, 2020
May 12, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Activation of beige/brown adipose tissue - Volume
Changes from baseline maximum Standardized Uptake Values (SUVmax) and mean Standardized Uptake Values (SUVmean), as assessed by PET/CT (FDG-18).
Three months
Activation of beige/brown adipose tissue - Temperature
Changes from baseline BAT temperature, as assessed by Thermal Imaging.
Three months
Activation of beige/brown adipose tissue - Adipokines
Changes from baseline BAT adipokines, as assessed by ELISA.
Three months
Activation of beige/brown adipose tissue - Activation Genes
Changes from baseline BAT activation genes, as assessed by PCR.
Three months
Secondary Outcomes (5)
Basal metabolic rates (BMR)
Three months
Metabolic markers
Three months
Hormones
Three months
Inflammatory markers
Three months
Insulin Sensitivity
Three months
Study Arms (2)
FMD Group
EXPERIMENTALParticipants will be requested to follow a Fasting Mimicking Diet, for three consecutive months. Before and after the intervention dietary intake and physical activity data, evaluation of beige/brown adipose tissue activation, anthropometric measures and body composition (DEXA scan), lipid profile and inflammatory markers.
Control Group
NO INTERVENTIONParticipants will be requested to continue with their habitual eating habits, for three consecutive months. Before and after the intervention dietary intake and physical activity data, evaluation of beige/brown adipose tissue activation, anthropometric measures and body composition (DEXA scan), lipid profile and inflammatory markers.
Interventions
Participants will be requested to follow three cycles (of 5 day each), for three consecutive months, of a Fasting Mimicking Diet, a plant-based, low-calorie, low-protein, low-carbohydrate, high-unsaturated fat diet. For the remaining 25 days of each month, participants should continue with their habitual eating habits.
Eligibility Criteria
You may qualify if:
- Body mass index (BMI) ≥ 25 and \< 30kg/m2.
You may not qualify if:
- Residing outside of Campinas county;
- Pregnant or lactating women;
- Patients with severe, non-stabilized neurological or psychiatric problems;
- Use of anti-obesity or lipid-lowering medication;
- Use of adrenergic or benzodiazepine drugs;
- Use of illicit drugs;
- Individuals with neoplasms, transmissible diseases, rheumatic disease, hepatic or renal insufficiency, non-treated thyroid dysfunction, diabetes mellitus, cardiovascular disease, history of fainting, active infection;
- Individuals who are allergic to nuts, soybean, oats, sesame or celery;
- Individuals who have had a change of more than 5% of their body weight in the last six months;
- Individuals who are carrying some kind of diet or modification to their habitual eating habits.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Medical Sciences - University of Campinas
Campinas, São Paulo, 13083-887, Brazil
Related Publications (3)
Carpentier AC, Blondin DP, Virtanen KA, Richard D, Haman F, Turcotte EE. Brown Adipose Tissue Energy Metabolism in Humans. Front Endocrinol (Lausanne). 2018 Aug 7;9:447. doi: 10.3389/fendo.2018.00447. eCollection 2018.
PMID: 30131768BACKGROUNDLeitner BP, Huang S, Brychta RJ, Duckworth CJ, Baskin AS, McGehee S, Tal I, Dieckmann W, Gupta G, Kolodny GM, Pacak K, Herscovitch P, Cypess AM, Chen KY. Mapping of human brown adipose tissue in lean and obese young men. Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):8649-8654. doi: 10.1073/pnas.1705287114. Epub 2017 Jul 24.
PMID: 28739898BACKGROUNDRachid B, van de Sande-Lee S, Rodovalho S, Folli F, Beltramini GC, Morari J, Amorim BJ, Pedro T, Ramalho AF, Bombassaro B, Tincani AJ, Chaim E, Pareja JC, Geloneze B, Ramos CD, Cendes F, Saad MJ, Velloso LA. Distinct regulation of hypothalamic and brown/beige adipose tissue activities in human obesity. Int J Obes (Lond). 2015 Oct;39(10):1515-22. doi: 10.1038/ijo.2015.94. Epub 2015 May 21.
PMID: 25994805BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marcela R Simoes, MS Candidate
University of Campinas
- STUDY DIRECTOR
Licio A Velloso, Professor
University of Campinas
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 4, 2020
First Posted
May 13, 2020
Study Start
May 1, 2020
Primary Completion
July 1, 2021
Study Completion
July 1, 2022
Last Updated
May 13, 2020
Record last verified: 2020-05